loading
CBPR0002
CBPR0002
Availability: | |
---|---|
The GJB2 p.G4D Genomic DNA Ref Std is a meticulously characterized reference material designed for routine quality control of clinical genetic testing workflows targeting the p.G4D mutation in the GJB2 gene, a primary cause of hereditary hearing loss. This standard contains genomic DNA with a heterozygous p.G4D (c.10G>A) mutation at a precisely calibrated 50% mutant allele frequency, representing the genetic profile of affected individuals. Manufactured to mimic the matrix characteristics of clinical specimens, it provides a consistent reference for validating the accuracy and reproducibility of GJB2 mutation detection assays in diagnostic laboratories. With comprehensive documentation supporting regulatory compliance, this standard is an essential tool for ensuring reliable results in hearing loss genetics testing .
Contains the pathogenic p.G4D mutation in heterozygous state, the most common GJB2 variant in several global populations. The mutation is verified by Sanger sequencing with >99.9% accuracy and digital droplet PCR confirming the 50% mutant allele frequency (±3% tolerance). This enables precise calibration of diagnostic thresholds for mutation calling .
Processed from whole blood using standard clinical extraction protocols to preserve:
• Native DNA fragmentation pattern (average 15-20 kb)
• Natural nucleosome structure
• Typical levels of cytosine methylation in the GJB2 promoter region
• Endogenous PCR inhibitors at physiological concentrations (≤0.5 ng/μL hemoglobin)
Each lot undergoes rigorous testing including:
• Stability testing under simulated shipping conditions
• Inter-lot variability assessment (<5% coefficient of variation)
• Compatibility testing with common clinical assay kits
• Long-term storage stability verification
Certificate of analysis includes detailed performance characteristics across multiple platforms.
Include in every diagnostic run as an external control at 20 ng input per reaction. Use to:
• Verify assay performance on each testing day
• Monitor technician proficiency
• Detect reagent lot-to-lot variations
• Ensure instrument calibration stability
Incorporate into assay validation to demonstrate:
• Analytical sensitivity (>99% detection rate)
• Analytical specificity (>99% precision)
• Inter-run reproducibility (CV <3%)
• Robustness across acceptable input ranges (10-50 ng DNA)
Reconstitute lyophilized DNA in 100 μL molecular biology-grade water to achieve 50 ng/μL working concentration. Allow to stand at room temperature for 15 minutes, then mix gently by inversion. Do not vortex. Store reconstituted aliquots at -20°C for up to 6 months.
GJB2 mutations account for 20-50% of non-syndromic congenital hearing loss cases worldwide, making it the most common genetic cause. Accurate detection of mutations like p.G4D enables definitive diagnosis, recurrence risk calculation, and appropriate management including early intervention services .
It meets CLIA and CAP requirements for external quality controls, providing traceable reference values with uncertainty estimates. Comprehensive documentation includes method validation data, stability studies, and performance characteristics across platforms to support regulatory submissions .
Yes, the standard is validated for use with all common clinical methods including allele-specific PCR, TaqMan assays, Sanger sequencing, and targeted NGS panels. Performance data for each method is provided in the certificate of analysis .
Unopened vials are stable at -20°C for 36 months. After reconstitution:
• -20°C storage: stable for 6 months (up to 3 freeze-thaw cycles)
• 4°C storage: stable for 30 days
• Room temperature: stable for 8 hours (≤25°C)
Product Information | EPCAM Deletion Reference Standard |
Catalog ID | CBPR0002 |
Format | Genomic DNA |
Intended Use | Research Use Only |
Unit Size | 1ug |
Sanger sequencing | Download |
Storage | 2-8°C |
Expiry | 36 months from the date of manufacture |
Technical Data
Product Information | EPCAM Deletion Reference Standard |
Gene | EPCAM |
DNA Change | N/A |
AA Change | N/A |
Zygosity | Heterozygous |
Allelic Frequency | 50% |
Chr position (GRCh37) | chr2:47611950-47614370 del |
Buffer | Tris-EDTA |
Product application
1.Evaluate the stability of the experiment and analysis process
2.Negative and negative reference/quality control products
The GJB2 p.G4D Genomic DNA Ref Std is a meticulously characterized reference material designed for routine quality control of clinical genetic testing workflows targeting the p.G4D mutation in the GJB2 gene, a primary cause of hereditary hearing loss. This standard contains genomic DNA with a heterozygous p.G4D (c.10G>A) mutation at a precisely calibrated 50% mutant allele frequency, representing the genetic profile of affected individuals. Manufactured to mimic the matrix characteristics of clinical specimens, it provides a consistent reference for validating the accuracy and reproducibility of GJB2 mutation detection assays in diagnostic laboratories. With comprehensive documentation supporting regulatory compliance, this standard is an essential tool for ensuring reliable results in hearing loss genetics testing .
Contains the pathogenic p.G4D mutation in heterozygous state, the most common GJB2 variant in several global populations. The mutation is verified by Sanger sequencing with >99.9% accuracy and digital droplet PCR confirming the 50% mutant allele frequency (±3% tolerance). This enables precise calibration of diagnostic thresholds for mutation calling .
Processed from whole blood using standard clinical extraction protocols to preserve:
• Native DNA fragmentation pattern (average 15-20 kb)
• Natural nucleosome structure
• Typical levels of cytosine methylation in the GJB2 promoter region
• Endogenous PCR inhibitors at physiological concentrations (≤0.5 ng/μL hemoglobin)
Each lot undergoes rigorous testing including:
• Stability testing under simulated shipping conditions
• Inter-lot variability assessment (<5% coefficient of variation)
• Compatibility testing with common clinical assay kits
• Long-term storage stability verification
Certificate of analysis includes detailed performance characteristics across multiple platforms.
Include in every diagnostic run as an external control at 20 ng input per reaction. Use to:
• Verify assay performance on each testing day
• Monitor technician proficiency
• Detect reagent lot-to-lot variations
• Ensure instrument calibration stability
Incorporate into assay validation to demonstrate:
• Analytical sensitivity (>99% detection rate)
• Analytical specificity (>99% precision)
• Inter-run reproducibility (CV <3%)
• Robustness across acceptable input ranges (10-50 ng DNA)
Reconstitute lyophilized DNA in 100 μL molecular biology-grade water to achieve 50 ng/μL working concentration. Allow to stand at room temperature for 15 minutes, then mix gently by inversion. Do not vortex. Store reconstituted aliquots at -20°C for up to 6 months.
GJB2 mutations account for 20-50% of non-syndromic congenital hearing loss cases worldwide, making it the most common genetic cause. Accurate detection of mutations like p.G4D enables definitive diagnosis, recurrence risk calculation, and appropriate management including early intervention services .
It meets CLIA and CAP requirements for external quality controls, providing traceable reference values with uncertainty estimates. Comprehensive documentation includes method validation data, stability studies, and performance characteristics across platforms to support regulatory submissions .
Yes, the standard is validated for use with all common clinical methods including allele-specific PCR, TaqMan assays, Sanger sequencing, and targeted NGS panels. Performance data for each method is provided in the certificate of analysis .
Unopened vials are stable at -20°C for 36 months. After reconstitution:
• -20°C storage: stable for 6 months (up to 3 freeze-thaw cycles)
• 4°C storage: stable for 30 days
• Room temperature: stable for 8 hours (≤25°C)
Product Information | EPCAM Deletion Reference Standard |
Catalog ID | CBPR0002 |
Format | Genomic DNA |
Intended Use | Research Use Only |
Unit Size | 1ug |
Sanger sequencing | Download |
Storage | 2-8°C |
Expiry | 36 months from the date of manufacture |
Technical Data
Product Information | EPCAM Deletion Reference Standard |
Gene | EPCAM |
DNA Change | N/A |
AA Change | N/A |
Zygosity | Heterozygous |
Allelic Frequency | 50% |
Chr position (GRCh37) | chr2:47611950-47614370 del |
Buffer | Tris-EDTA |
Product application
1.Evaluate the stability of the experiment and analysis process
2.Negative and negative reference/quality control products
General Information
Product Information | EPCAM Deletion Reference Standard |
Catalog ID | CBPR0002 |
Format | Genomic DNA |
Intended Use | Research Use Only |
Unit Size | 1ug |
Sanger sequencing | Download |
Storage | 2-8°C |
Expiry | 36 months from the date of manufacture |
General Information
Product Information | EPCAM Deletion Reference Standard |
Catalog ID | CBPR0002 |
Format | Genomic DNA |
Intended Use | Research Use Only |
Unit Size | 1ug |
Sanger sequencing | Download |
Storage | 2-8°C |
Expiry | 36 months from the date of manufacture |
Detailed Data
Product Information | EPCAM Deletion Reference Standard |
Gene | EPCAM |
DNA Change | N/A |
AA Change | N/A |
Zygosity | Heterozygous |
Allelic Frequency | 50% |
Chr position (GRCh37) | chr2:47611950-47614370 del |
Buffer | Tris-EDTA |
Detailed Data
Product Information | EPCAM Deletion Reference Standard |
Gene | EPCAM |
DNA Change | N/A |
AA Change | N/A |
Zygosity | Heterozygous |
Allelic Frequency | 50% |
Chr position (GRCh37) | chr2:47611950-47614370 del |
Buffer | Tris-EDTA |
Product Application
1.Evaluate the stability of the experiment and analysis process
2.Negative and negative reference/quality control products
Product Application
1.Evaluate the stability of the experiment and analysis process
2.Negative and negative reference/quality control products